4 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
in HF and CKD. ... in HF and CKD. ... in HFrEF on GDMT ... on GDMT, with or ... visualabstract #table
Guideline-Directed Medical Therapy (GDMT) in HFrEF and CKD

 • Class I pillars of HFrEF GDMT across
Medical Therapy (GDMT ... ) in HFrEF and CKD ... GDMT across the ... diuretics, MRA, SGLT2i ... #CKD #HFrEF #management
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
angiotensin-receptor blocker; CAD ... ejection fraction; GDMT ... heart failure; HFpEF ... ejection fraction; HFrEF ... #CHF #Congestive
Acute and Chronic Causes of Dyspnea - Differential Diagnosis
Pulmonary/Chest Wall:
 • Acute: Trauma, COPD exacerbation, Asthma
Pleural effusion, Pneumonia ... decompensated CHF ... Pericarditis, CAD ... , HFrEF/HFpEF, Intracardiac